SHANDONG: The Proton Clinical Research Center at Shandong Cancer Hospital, part of Shandong First Medical University, has successfully treated over 300 cancer patients using proton therapy in the past five months, achieving notable results. Its recent focus is on children, addressing the disturbing rise in childhood cancer rates in China.

According to a report published by China Daily, findings from the National Childhood Cancer Surveillance Annual Report indicate that between 2019 and 2020, the incidence of childhood cancer amounted to 125.72 cases per million. Notably, children aged 1 to 4 exhibit heightened vulnerability. It is of concern that malignant tumors have become the second most prevalent cause of non-accidental fatalities among children.

Proton therapy offers new hope, with many patients experiencing symptom relief or remission. Yu Jinming, hospital president and Chinese Academy of Engineering academician, pursued proton therapy after studying it at Harvard Medical School in 1995. He was determ
ined to bring this advanced treatment to China, and in 2023, he realized this vision.

Unlike traditional radiation, proton therapy precisely targets tumors, sparing healthy tissue and reducing side effects. At Shandong, it has effectively treated head, neck, chest, and abdominal tumors, particularly in children.

Yu highlighted that the therapy’s high cost can deter patients. To combat this, the center has built a multidisciplinary team to offer comprehensive cancer care. Despite challenges like diagnosis delays, limited awareness, and financial burdens, Yu believes that advanced treatment like proton therapy, alongside better insurance, could significantly improve outcomes for children with cancer.

Source: Emirates News Agency